Sorry, you need to enable JavaScript to visit this website.

CALAN® SR (verapamil sustained release oral caplets) Principal Display Panel

PRINCIPAL DISPLAY PANEL - 120 mg Caplet Bottle Label

NDC 0025-1901-31

Pfizer

Calan® SR
(verapamil
hydrochloride) caplets
SUSTAINED-RELEASE

120 mg

100 Caplets
Rx only

PRINCIPAL DISPLAY PANEL - 120 mg Caplet Bottle Label

PRINCIPAL DISPLAY PANEL - 180 mg Caplet Bottle Label

NDC 0025-1911-31

Pfizer

Calan® SR
(verapamil
hydrochloride) caplets
SUSTAINED-RELEASE

180 mg

100 Caplets
Rx only

PRINCIPAL DISPLAY PANEL - 180 mg Caplet Bottle Label

PRINCIPAL DISPLAY PANEL - 240 mg Caplet Bottle Label

NDC 0025-1891-31

Pfizer

Calan® SR
(verapamil
hydrochloride) caplets
SUSTAINED-RELEASE

240 mg

100 Caplets
Rx only

PRINCIPAL DISPLAY PANEL - 240 mg Caplet Bottle Label

PRINCIPAL DISPLAY PANEL - 120 mg Tablet Bottle Label

NDC 0025-2712-31
Pfizer

Calan® SR
(verapamil hydrochloride)
extended-release tablets

120 mg*

100 Tablets
Rx only

Principal Display Panel - 120 mg Tablet Bottle Label

PRINCIPAL DISPLAY PANEL - 180 mg Tablet Bottle Label

NDC 0025-2818-31
Pfizer

Calan® SR
(verapamil hydrochloride)
extended-release tablets

180 mg*

100 Tablets
Rx only

Principal Display Panel - 180 mg Tablet Bottle Label

PRINCIPAL DISPLAY PANEL - 240 mg Tablet Bottle Label

NDC 0025-2924-31
Pfizer

Calan® SR
(verapamil hydrochloride)
extended-release tablets

240 mg*

100 Tablets
Rx only

Principal Display Panel - 240 mg Tablet Bottle Label

What's New

No Current Announcements.

Contact Pfizer Medical

Search

Please enter your search term(s) for CALAN® SR